Paldara Pharmaceuticals
PrivateLast Round
Accelerator
Sep 10, 2024
Total Funding Raised
$120,000
Company Overview
Paldara Pharmaceuticals is a biotechnology company that develops bacteriophage-based therapeutics and advanced hydrogel drug delivery platforms to prevent and treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paldara Pharmaceuticals Comparables
Compare Paldara Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phiogen | 79% | |
| TechnoPhage | 77% | |
| Locus Biosciences | 75% | |
Paldara Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 10, 2024 | ||||
| Accelerator | Mar 27, 2024 | ||||
| Accelerator | Jul 13, 2023 | ||||
| Accelerator | May 4, 2023 | ||||
| Grant | Mar 21, 2022 | ||||
Accelerator | Nov 9, 2021 |
Key People
Founding team and executive leadership
Paldara Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Grant |
| Capital Factory | Accelerator |
| gBETA | Accelerator |
| JPMorgan Chase & Co. | Accelerator |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2025
Developing a hydrogel platform for bacteriophage delivery in collaboration with Mayo Clinic.
- Aug 14, 2025
Partnering with Mayo Clinic on a novel hydrogel drug delivery system.
Paldara Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paldara Pharmaceuticals's valuation, stock price, and market status.